These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20453442)

  • 41. A genome-wide association analysis identifies NMNAT2 and HCP5 as susceptibility loci for Kawasaki disease.
    Kim JJ; Yun SW; Yu JJ; Yoon KL; Lee KY; Kil HR; Kim GB; Han MK; Song MS; Lee HD; Ha KS; Sohn S; Johnson TA; Takahashi A; Kubo M; Tsunoda T; Ito K; Onouchi Y; Hong YM; Jang GY; Lee JK;
    J Hum Genet; 2017 Dec; 62(12):1023-1029. PubMed ID: 28855716
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cyclosporin A treatment for refractory Kawasaki disease].
    Suzuki H; Suenaga T; Kakimoto N; Takeuchi T; Shibuta S
    Nihon Rinsho; 2014 Sep; 72(9):1636-40. PubMed ID: 25518415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genome-wide linkage and association mapping identify susceptibility alleles in ABCC4 for Kawasaki disease.
    Khor CC; Davila S; Shimizu C; Sheng S; Matsubara T; Suzuki Y; Newburger JW; Baker A; Burgner D; Breunis W; Kuijpers T; Wright VJ; Levin M; Hibberd ML; Burns JC;
    J Med Genet; 2011 Jul; 48(7):467-72. PubMed ID: 21571869
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Understanding the pathogenesis of Kawasaki disease by network and pathway analysis.
    Lv YW; Wang J; Sun L; Zhang JM; Cao L; Ding YY; Chen Y; Dou JJ; Huang J; Tang YF; Wu WT; Cui WR; Lv HT
    Comput Math Methods Med; 2013; 2013():989307. PubMed ID: 23533546
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of novel locus associated with coronary artery aneurysms and validation of loci for susceptibility to Kawasaki disease.
    Hoggart C; Shimizu C; Galassini R; Wright VJ; Shailes H; Bellos E; Herberg JA; Pollard AJ; O'Connor D; Choi SW; Seaby EG; Menikou S; Hibberd M; Sallah N; Burgner D; Brogan P; Patel H; Kim J; Tremoulet AH; Salo E; van Stijn D; Kuijpers T; Burns JC; Levin M; ; ;
    Eur J Hum Genet; 2021 Dec; 29(12):1734-1744. PubMed ID: 33772158
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of KCNN2 as a susceptibility locus for coronary artery aneurysms in Kawasaki disease using genome-wide association analysis.
    Kim JJ; Park YM; Yoon D; Lee KY; Seob Song M; Doo Lee H; Kim KJ; Park IS; Nam HK; Weon Yun S; Ki Han M; Mi Hong Y; Young Jang G; Lee JK;
    J Hum Genet; 2013 Aug; 58(8):521-5. PubMed ID: 23677057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Variations in ORAI1 Gene Associated with Kawasaki Disease.
    Onouchi Y; Fukazawa R; Yamamura K; Suzuki H; Kakimoto N; Suenaga T; Takeuchi T; Hamada H; Honda T; Yasukawa K; Terai M; Ebata R; Higashi K; Saji T; Kemmotsu Y; Takatsuki S; Ouchi K; Kishi F; Yoshikawa T; Nagai T; Hamamoto K; Sato Y; Honda A; Kobayashi H; Sato J; Shibuta S; Miyawaki M; Oishi K; Yamaga H; Aoyagi N; Yoshiyama M; Miyashita R; Murata Y; Fujino A; Ozaki K; Kawasaki T; Abe J; Seki M; Kobayashi T; Arakawa H; Ogawa S; Hara T; Hata A; Tanaka T
    PLoS One; 2016; 11(1):e0145486. PubMed ID: 26789410
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of COL11A2 polymorphism with susceptibility to Kawasaki disease and development of coronary artery lesions.
    Sheu JJ; Lin YJ; Chang JS; Wan L; Chen SY; Huang YC; Chan C; Chiu IW; Tsai FJ
    Int J Immunogenet; 2010 Dec; 37(6):487-92. PubMed ID: 20618517
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease.
    Kariyazono H; Ohno T; Khajoee V; Ihara K; Kusuhara K; Kinukawa N; Mizuno Y; Hara T
    Pediatr Res; 2004 Dec; 56(6):953-9. PubMed ID: 15470196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic variants in PLCB4/PLCB1 as susceptibility loci for coronary artery aneurysm formation in Kawasaki disease in Han Chinese in Taiwan.
    Lin YJ; Chang JS; Liu X; Tsang H; Chien WK; Chen JH; Hsieh HY; Hsueh KC; Shiao YT; Li JP; Lin CW; Lai CH; Wu JY; Chen CH; Lin JG; Lin TH; Liao CC; Huang SM; Lan YC; Ho TJ; Liang WM; Yeh YC; Lin JC; Tsai FJ
    Sci Rep; 2015 Oct; 5():14762. PubMed ID: 26434682
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Roles of Genetic Factors in Kawasaki Disease: A Systematic Review and Meta-analysis of Genetic Association Studies.
    Xie X; Shi X; Liu M
    Pediatr Cardiol; 2018 Feb; 39(2):207-225. PubMed ID: 29098351
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-density genotyping of immune loci in Kawasaki disease and IVIG treatment response in European-American case-parent trio study.
    Shendre A; Wiener HW; Zhi D; Vazquez AI; Portman MA; Shrestha S
    Genes Immun; 2014 Dec; 15(8):534-42. PubMed ID: 25101798
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetics of Kawasaki disease: what we know and don't know.
    Onouchi Y
    Circ J; 2012; 76(7):1581-6. PubMed ID: 22789975
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Genetic susceptibility in children with incomplete Kawasaki disease].
    Jin XQ; Liu P; Zhang QP
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jul; 17(7):663-7. PubMed ID: 26182267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The -590 C/T and 8375 A/G interleukin-4 polymorphisms are not associated with Kawasaki disease in Taiwanese children.
    Huang FY; Chang TY; Chen MR; Lee HC; Chiu NC; Chi H; Hsu CH; Lin SP; Liu HF; Chen WF; Chu CC; Lin M; Lee YJ
    Hum Immunol; 2008 Jan; 69(1):52-7. PubMed ID: 18295676
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of interleukin 18 promoter polymorphisms in susceptibility to Kawasaki disease in Taiwan.
    Hsueh KC; Lin YJ; Chang JS; Wan L; Tsai YH; Tsai CH; Tsai FJ
    J Rheumatol; 2008 Jul; 35(7):1408-13. PubMed ID: 18484687
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic epistasis between killer immunoglobulin-like receptors and human leukocyte antigens in Kawasaki disease susceptibility.
    Bossi G; Mannarino S; Pietrogrande MC; Salice P; Dellepiane RM; Cremaschi AL; Corana G; Tozzo A; Capittini C; De Silvestri A; Tinelli C; Pasi A; Martinetti M
    Genes Immun; 2015 Oct; 16(7):481-7. PubMed ID: 26335810
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disruption of vascular homeostasis in patients with Kawasaki disease: involvement of vascular endothelial growth factor and angiopoietins.
    Breunis WB; Davila S; Shimizu C; Oharaseki T; Takahashi K; van Houdt M; Khor CC; Wright VJ; Levin M; Burns JC; Burgner D; Hibberd ML; Kuijpers TW;
    Arthritis Rheum; 2012 Jan; 64(1):306-15. PubMed ID: 21905000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CYP2E1 Gene Polymorphisms Related to the Formation of Coronary Artery Lesions in Kawasaki Disease.
    Chang LS; Hsu YW; Lu CC; Lo MH; Hsieh KS; Li SC; Chang WC; Kuo HC
    Pediatr Infect Dis J; 2017 Nov; 36(11):1039-1043. PubMed ID: 28650933
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic variations of HLA-DRB1 and susceptibility to Kawasaki disease in Taiwanese children.
    Huang FY; Chang TY; Chen MR; Hsu CH; Lee HC; Lin SP; Kao HA; Chiu NC; Chi H; Liu TY; Liu HF; Dang CW; Chu CC; Lin M; Sung TC; Lee YJ
    Hum Immunol; 2007 Jan; 68(1):69-74. PubMed ID: 17207714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.